ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,731.56
      0.15%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. PDS Biotechnology Corporation (PDSB)

      7. PDS Biotechnology Corporation (PDSB) Financials

      PDS Biotechnology Corporation

      PDS Biotechnology Corporation (PDSB)

      NASDAQ
      3.12
      0.11
      (3.65%)
      Closed July 06 4:00PM
      Delayed by 15 minutes
      3.12
      -0.01
      (-0.32%)
      After Hours: 4:49PM
      Delayed by 15 minutes

      PDS Biotechnology Corporation Financial Summary

      The current PDSB market cap is 114.44M. The company's latest EPS is USD -1.1707 and P/E is -2.67.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -9.42M-12.7M-10.52M-10.41M-10.1M
      Net Income -9.66M-11.54M-10.85M-10.9M-10.6M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -21.04M-14.9M-21.44M-41.67M-43.05M
      Net Income -7M-14.85M-16.92M-40.86M-42.94M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 68.45M63.75M57.19M59.39M69.01M
      Total Liabilities 27.44M31.31M32.7M33.26M31.82M
      Total Equity 41.01M32.44M24.48M26.13M37.18M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 14.49M30.89M67.2M77.01M59.39M
      Total Liabilities 2.79M3.76M3.99M33.01M33.26M
      Total Equity 11.7M27.13M63.21M44M26.13M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -13.19M-18M-25.18M-33.64M-9.94M
      Investing N/A N/A N/A N/A N/A
      Financing 4.57M4.81M5.61M16.38M20.01M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -18.07M-13.15M-12.49M-25.71M-33.64M
      Investing 29.38M N/A N/A N/A N/A
      Financing 750k29.83M48.89M34.29M16.38M

      Stats and Ratios

      Market Cap 114.44M
      Price to Earnings Ratio -2.67
      Price to Sales Ratio 0
      Price to Cash Ratio 2.03
      Price to Book Ratio 4.39
      Dividend Yield -

      Share Statistics

      Shares Outstanding 36.68M
      Average Volume (1 week) 1.41M
      Average Volume (1 Month) 764.04k
      52 Week Change -37.35%
      52 Week High 6.85
      52 Week Low 2.53
      Spread (Intraday) 0.12 (3.85%)

      Company Info

      Company Name PDS Biotechnology Corporation
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.pdsbiotech.com
      Industry pharmaceutical preparations (2834)